Cargando…

SARS-CoV-2 IGM and IGG rapid serologic test for the diagnosis of COVID-19 in the emergency department

• RT-PCR for SARS-CoV-2′s diagnostic has many false negatives and long turnaround times. • In our study 20% of RT-PCR negative patients had a rapid Sars-CoV2 IgG/IgM positive. • Rapid SARS-CoV2 IgG/IgM may be used as a complementary assay to the RT-PCR. • They can be useful in emergency patient'...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cancella de Abreu, Marta, Choquet, Christophe, Petit, Héloise, Bouzid, Donia, Damond, Florence, Marot, Stephane, Ferre, Valentine Marie, Burrel, Sonia, Boutolleau, David, Houdou-Fidouh, Nadhira, Marcelin, Anne-Geneviève, Descamps, Diane, Hausfater, Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392071/ https://www.ncbi.nlm.nih.gov/pubmed/32739490 http://dx.doi.org/10.1016/j.jinf.2020.07.032

Ejemplares similares

Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott)
por: Charpentier, Charlotte, et al.
Publicado: (2020)

The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients
por: Teyssou, Elisa, et al.
Publicado: (2021)

Evaluation of the RealStar® SARS-CoV-2 RT-PCR kit RUO performances and limit of detection
por: Visseaux, Benoit, et al.
Publicado: (2020)

Evaluation of three extraction-free SARS-CoV-2 RT-PCR assays: A feasible alternative approach with low technical requirements
por: Visseaux, Benoit, et al.
Publicado: (2021)

The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients
por: Teyssou, Elisa, et al.
Publicado: (2021)

Viral epidemiology and SARS‐CoV‐2 co‐infections with other respiratory viruses during the first COVID‐19 wave in Paris, France
por: Le Hingrat, Quentin, et al.
Publicado: (2021)

Efficacy of Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine in Patients With Thoracic Cancer: A Prospective Study Supporting a Third Dose in Patients With Minimal Serologic Response After Two Vaccine Doses
por: Gounant, Valérie, et al.
Publicado: (2022)

Co-infection of SARS-CoV-2 with other respiratory viruses and performance of lower respiratory tract samples for the diagnosis of COVID-19
por: Burrel, Sonia, et al.
Publicado: (2021)

Clinical presentation of Covid-19 in health care workers from a French University Hospital
por: Jary, Aude, et al.
Publicado: (2020)

Alpha (B.1.1.7) and Delta (B.1.617.2 – AY.40) SARS-CoV-2 variants present strong neutralization decay at M4 post-vaccination and a faster replication rates than D614G (B.1) lineage
por: Lebourgeois, Samuel, et al.
Publicado: (2022)

Agreement of respiratory viruses' detection between nasopharyngeal swab and bronchoalveolar lavage in adults admitted for pneumonia: a retrospective study
por: Bouzid, Donia, et al.
Publicado: (2023)

Long-term evolution of humoral immune response after SARS-CoV-2 infection
por: Teyssou, Elisa, et al.
Publicado: (2022)

Added value of rapid respiratory syndromic testing at point of care versus central laboratory testing: a controlled clinical trial
por: Bouzid, Donia, et al.
Publicado: (2021)

Interpretation of SARS-CoV-2 replication according to RT-PCR crossing threshold value
por: Marot, Stéphane, et al.
Publicado: (2021)

Performance of 30 commercial SARS-CoV-2 serology assays in testing symptomatic COVID-19 patients
por: Vauloup-Fellous, Christelle, et al.
Publicado: (2021)

Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19
por: Klement-Frutos, Elise, et al.
Publicado: (2021)

Novel mutations in antiviral multiresistant HSV‐2 genital lesion: A case report
por: Khellaf, Lucas, et al.
Publicado: (2022)

Serologic Tests of IgG and IgM Antibodies and IgG Avidity for Diagnosis of Ocular Toxoplasmosis
por: Rahimi-Esboei, Bahman, et al.
Publicado: (2018)

Vaccine Ab neutralization against Omicron and SARS-CoV-2 variants using neutralization and specific ELISA assays
por: Ferré, Valentine Marie, et al.
Publicado: (2022)

Medical features of COVID-19 and influenza infection: A comparative study in Paris, France
por: Faury, Hélène, et al.
Publicado: (2021)

Future of Antiretroviral Drugs and Evolution of HIV-1 Drug Resistance
por: Charpentier, Charlotte, et al.
Publicado: (2023)

Molecular confirmation of HIV-1 and HIV-2 coinfections among initially serologically dually-reactive samples from patients living in West Africa
por: Tchounga, Boris K., et al.
Publicado: (2023)

Evolution of viral quasispecies during SARS-CoV-2 infection
por: Jary, Aude, et al.
Publicado: (2020)

Serologic Cross-Reactivity of Human IgM and IgG Antibodies to Five Species of Ebola Virus
por: MacNeil, Adam, et al.
Publicado: (2011)

Performance Characteristics of the Vidas SARS-CoV-2 IgM and IgG Serological Assays
por: Renard, Nathalie, et al.
Publicado: (2021)

Evaluation of eight commercial Zika virus IgM and IgG serology assays for diagnostics and research
por: Low, Swee Ling, et al.
Publicado: (2021)

Decreasing humoral response among healthcare workers up to 4 months after two doses of BNT162b2 vaccine
por: Ferré, Valentine Marie, et al.
Publicado: (2022)

Contribution of rapid lateral flow assays from capillary blood specimens to the diagnosis of COVID-19 in symptomatic healthcare workers: a pilot study in a university hospital, Paris, France
por: Charpentier, Charlotte, et al.
Publicado: (2021)

Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers
por: Marot, Stéphane, et al.
Publicado: (2021)

Author Correction: Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers
por: Marot, Stéphane, et al.
Publicado: (2021)

Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives
por: Le Hingrat, Quentin, et al.
Publicado: (2021)

Corrigendum to ‘detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives’
por: Le Hingrat, Quentin, et al.
Publicado: (2021)

Detection of IgM Antibrucella Antibody in the Absence of IgGs: A Challenge for the Clinical Interpretation of Brucella Serology
por: Solís García del Pozo, Julián, et al.
Publicado: (2014)

False positive Herpes Simplex IgM serology in COVID-19 patients correlates with SARS-CoV-2 IgM/IgG seropositivity
por: Vandervore, Laura, et al.
Publicado: (2022)

Comparison of Rapid and Automated Antigen Detection Tests for the Diagnosis of SARS-CoV-2 Infection
por: Petonnet, Dorian, et al.
Publicado: (2022)

Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the First Rapid Multiplex PCR Commercial Assay for SARS-CoV-2 Detection
por: Visseaux, Benoit, et al.
Publicado: (2020)

Head-to-Head Accuracy Comparison of Three Commercial COVID-19 IgM/IgG Serology Rapid Tests
por: Andrey, Diego O., et al.
Publicado: (2020)

Accuracy of the serological detection of IgG and IgM to SARS-Cov-2: a prospective, cross-sectional study
por: Pecoraro, Valentina, et al.
Publicado: (2021)

Performance of a serological IgM and IgG qualitative test for COVID-19 diagnosis: An experimental study in Brazil
por: Freire de Melo, Fabrício, et al.
Publicado: (2022)

Verification and Comparison of Qualitative Serological Assays for Anti-SARS-COV-2 IgM and IgG Antibodies Detection
por: Štebih, Maša, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2pjnjl77o4asf3kh09jr68riml